Basal levels of CCL2 and TrkC in the bilateral L3/4 DRGs from the vehicle plus NT3 siRNA-treated CD1 male and female mice or from the vehicle plus tamoxifen-treated NT3 cKD male mice were not altered (Fig. 9A–C). This evidence concerns the gene NTRK3 and chronic kidney disease.